๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

714 HBSAG LEVELS DURING THE FIRST 24 WEEKS OF PEGINTERFERON ALFA-2A [40KD] (PEGASYS) TREATMENT IN PATIENTS WITH HBEAG-NEGATIVE CHRONIC HEPATITIS B: THE PERSEAS COHORT

โœ Scribed by I. Goulis; E. Akriviadis; S. Karatapanis; M. Deutsch; G. Dalekos; M. Raptopoulou-Gigi; C. Drakoulis; G. Bakalos; G. Papatheodoridis


Book ID
117379858
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
58 KB
Volume
54
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


95 Peginterferon alfa-2A (40KD) (PEGASYS